Test bbBank bbFor bbPharmacology bbClear bband
bbSimple: bb
A bbGuide bbto bbDrug bbClassifications bband bbDosage
bbCalculations, bb
4th bbEdition bbby bbCynthia bbJ. bbWatkins bb
Chapters bb1 bb- bb21 bb
,
,Chapter bb1. bbHistory bbof bbPharmacology
Pharmacology bbClear bband bbSimple- bbA bbGuide bbto bbDrug bbClassifications bband
bbDosage bbCalculations bb4thbbEdition bbWatkins bbTest bbBank
1. A bbnurse bbworking bbin bbradiology bbadministers bbiodine bbto bba bbpatient
bbwho bbis bbhaving bba bbcomputedbbtomography bb(CT) bbscan. bbThe bbnurse
bbworking bbon bbthe bboncology bbunit bbadministers bbchemotherapy bbto
bbpatients bbwho bbhave bbcancer. bbAt bbthe bbPublic bbHealth bbDepartment,
bba bbnurse bbadministers bba bbmeasles-mumps-rubella bb(MMR) bbvaccine bbto
bba bb14-month-old bbchild bbas bba bbroutine bbimmunization. bbWhich bbbranch
bbof bbpharmacology bbbest bbdescribes bbthe bbactions bbof bball bbthree bbnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacology bbis bbthe bbstudy bbof bbthe bbbiologic bbeffects bbof bbchemicals.
bbNurses bbare bbinvolved bbwith bbclinical bbpharmacology bbor
bbpharmacotherapeutics, bbwhich bbis bba bbbranch bbof bbpharmacology bbthat
bbdeals bbwith bbthe bbuses bbof bbdrugs bbto bbtreat, bbprevent, bband
bbdiagnose bbdisease.bbThe bbradiology bbnurse bbis bbadministering bba bbdrug
bbto bbhelp bbdiagnose bba bbdisease. bbThe bboncology bbnurse bbis
bbadministering bba bbdrug bbto bbhelp bbtreat bba bbdisease.
bbPharmacoeconomics bbincludes bbany bbcosts bbinvolved bbin bbdrug
bbtherapy. bbPharmacodynamics bbinvolves bbhow bba bbdrug bbaffects bbthe
bbbody bband bbpharmacokinetics bbis bbhow bbthe bbbody bbacts bbon bbthe
bbbody.
2. A bbphysician bbhas bbordered bbintramuscular bb(IM) bbinjections bbof
bbmorphine, bba bbnarcotic, bbevery bb4 bbhours bbas bbneeded bbfor
bbpain bbin bba bbmotor bbvehicle bbaccident bbvictim. bbThe bbnurse
bbis bbaware bbthis bbdrug bbhas bba bbhigh bbabuse bbpotential.
bbUnder bbwhatbbcategory bbwould bbmorphine bbbe bbclassified?
A) Schedule bbI
B) Schedule bbII
C) Schedule bbIII
D) Schedule bbIV
ANSWER: B
, Feedback:
Narcotics bbwith bba bbhigh bbabuse bbpotential bbare bbclassified bbas
bbSchedule bbII bbdrugs bbbecause bbof bbsevere bbdependence
bbliability. bbSchedule bbI bbdrugs bbhave bbhigh bbabuse bbpotential
bband bbno bbaccepted bbmedical bbuse. bbSchedule bbIII bbdrugs
bbhave bba bblesser bbabuse bbpotential bbthan bbII bband bban
bbaccepted bbmedical bbuse. bbSchedule bbIV bbdrugs bbhavebblow
bbabuse bbpotential bband bblimited bbdependence bbliability.
3. When bbinvolved bbin bbphase bbIII bbdrug bbevaluation bbstudies,
bbwhat bbresponsibilitiesbbwould bbthe bbnurse bbhave?
A) Working bbwith bbanimals bbwho bbare bbgiven bbexperimental bbdrugs
B) Choosing bbappropriate bbpatients bbto bbbe bbinvolved bbin bbthe
bbdrug bbstudy
C) Monitoring bband bbobserving bbpatients bbclosely bbfor bbadverse
bbeffects
D) Conducting bbresearch bbto bbdetermine bbeffectiveness bbof bbthe
bbdrug
ANSWER: C
Feedback:
Phase bbIII bbstudies bbinvolve bbuse bbof bba bbdrug bbin bba bbvast
bbclinical bbpopulation bbin bbwhichbbpatients bbare bbasked bbto
bbrecord bbany bbsymptoms bbthey bbexperience bbwhile bbtaking bbthe
bbdrugs. bbNurses bbmay bbbe bbresponsible bbfor bbhelping bbcollect
bband bbanalyze bbthe bbinformation bbto bbbe bbshared bbwith bbthe
bbFood bband bbDrug bbAdministration bb(FDA) bbbutbbwould bbnot
bbconduct bbresearch bbindependently bbbecause bbnurses bbdo bbnot
bbprescribe bbmedications. bbUse bbof bbanimals bbin bbdrug bbtesting
bbis bbdone bbin bbthe bbpreclinical bbtrials. bbSelect bbpatients bbwho
bbare bbinvolved bbin bbphase bbII bbstudies bbto bbparticipate bbin
bbstudies bbwhere bbthe bbparticipants bbhave bbthe bbdisease bbthe
bbdrug bbis bbintended bbto bbtreat. bbThese bbpatients bbare
bbmonitored bbclosely bbfor bbdrug bbaction bband bbadverse bbeffects.
bbPhase bbI bbstudies bbinvolve bbhealthy bbhuman bbvolunteers bbwho
bbare bbusually bbpaid bbfor bbtheir bbparticipation. bbNurses bbmay
bbobserve bbfor bbadverse bbeffects bband bbtoxicity.
4. What bbconcept bbis bbconsidered bbwhen bbgeneric bbdrugs bbare
bbsubstituted bbfor bbbrandbbname bbdrugs?
A) Bioavailability
B) Critical bbconcentration
C) Distribution
D) Half-life
ANSWER: A
bbSimple: bb
A bbGuide bbto bbDrug bbClassifications bband bbDosage
bbCalculations, bb
4th bbEdition bbby bbCynthia bbJ. bbWatkins bb
Chapters bb1 bb- bb21 bb
,
,Chapter bb1. bbHistory bbof bbPharmacology
Pharmacology bbClear bband bbSimple- bbA bbGuide bbto bbDrug bbClassifications bband
bbDosage bbCalculations bb4thbbEdition bbWatkins bbTest bbBank
1. A bbnurse bbworking bbin bbradiology bbadministers bbiodine bbto bba bbpatient
bbwho bbis bbhaving bba bbcomputedbbtomography bb(CT) bbscan. bbThe bbnurse
bbworking bbon bbthe bboncology bbunit bbadministers bbchemotherapy bbto
bbpatients bbwho bbhave bbcancer. bbAt bbthe bbPublic bbHealth bbDepartment,
bba bbnurse bbadministers bba bbmeasles-mumps-rubella bb(MMR) bbvaccine bbto
bba bb14-month-old bbchild bbas bba bbroutine bbimmunization. bbWhich bbbranch
bbof bbpharmacology bbbest bbdescribes bbthe bbactions bbof bball bbthree bbnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacology bbis bbthe bbstudy bbof bbthe bbbiologic bbeffects bbof bbchemicals.
bbNurses bbare bbinvolved bbwith bbclinical bbpharmacology bbor
bbpharmacotherapeutics, bbwhich bbis bba bbbranch bbof bbpharmacology bbthat
bbdeals bbwith bbthe bbuses bbof bbdrugs bbto bbtreat, bbprevent, bband
bbdiagnose bbdisease.bbThe bbradiology bbnurse bbis bbadministering bba bbdrug
bbto bbhelp bbdiagnose bba bbdisease. bbThe bboncology bbnurse bbis
bbadministering bba bbdrug bbto bbhelp bbtreat bba bbdisease.
bbPharmacoeconomics bbincludes bbany bbcosts bbinvolved bbin bbdrug
bbtherapy. bbPharmacodynamics bbinvolves bbhow bba bbdrug bbaffects bbthe
bbbody bband bbpharmacokinetics bbis bbhow bbthe bbbody bbacts bbon bbthe
bbbody.
2. A bbphysician bbhas bbordered bbintramuscular bb(IM) bbinjections bbof
bbmorphine, bba bbnarcotic, bbevery bb4 bbhours bbas bbneeded bbfor
bbpain bbin bba bbmotor bbvehicle bbaccident bbvictim. bbThe bbnurse
bbis bbaware bbthis bbdrug bbhas bba bbhigh bbabuse bbpotential.
bbUnder bbwhatbbcategory bbwould bbmorphine bbbe bbclassified?
A) Schedule bbI
B) Schedule bbII
C) Schedule bbIII
D) Schedule bbIV
ANSWER: B
, Feedback:
Narcotics bbwith bba bbhigh bbabuse bbpotential bbare bbclassified bbas
bbSchedule bbII bbdrugs bbbecause bbof bbsevere bbdependence
bbliability. bbSchedule bbI bbdrugs bbhave bbhigh bbabuse bbpotential
bband bbno bbaccepted bbmedical bbuse. bbSchedule bbIII bbdrugs
bbhave bba bblesser bbabuse bbpotential bbthan bbII bband bban
bbaccepted bbmedical bbuse. bbSchedule bbIV bbdrugs bbhavebblow
bbabuse bbpotential bband bblimited bbdependence bbliability.
3. When bbinvolved bbin bbphase bbIII bbdrug bbevaluation bbstudies,
bbwhat bbresponsibilitiesbbwould bbthe bbnurse bbhave?
A) Working bbwith bbanimals bbwho bbare bbgiven bbexperimental bbdrugs
B) Choosing bbappropriate bbpatients bbto bbbe bbinvolved bbin bbthe
bbdrug bbstudy
C) Monitoring bband bbobserving bbpatients bbclosely bbfor bbadverse
bbeffects
D) Conducting bbresearch bbto bbdetermine bbeffectiveness bbof bbthe
bbdrug
ANSWER: C
Feedback:
Phase bbIII bbstudies bbinvolve bbuse bbof bba bbdrug bbin bba bbvast
bbclinical bbpopulation bbin bbwhichbbpatients bbare bbasked bbto
bbrecord bbany bbsymptoms bbthey bbexperience bbwhile bbtaking bbthe
bbdrugs. bbNurses bbmay bbbe bbresponsible bbfor bbhelping bbcollect
bband bbanalyze bbthe bbinformation bbto bbbe bbshared bbwith bbthe
bbFood bband bbDrug bbAdministration bb(FDA) bbbutbbwould bbnot
bbconduct bbresearch bbindependently bbbecause bbnurses bbdo bbnot
bbprescribe bbmedications. bbUse bbof bbanimals bbin bbdrug bbtesting
bbis bbdone bbin bbthe bbpreclinical bbtrials. bbSelect bbpatients bbwho
bbare bbinvolved bbin bbphase bbII bbstudies bbto bbparticipate bbin
bbstudies bbwhere bbthe bbparticipants bbhave bbthe bbdisease bbthe
bbdrug bbis bbintended bbto bbtreat. bbThese bbpatients bbare
bbmonitored bbclosely bbfor bbdrug bbaction bband bbadverse bbeffects.
bbPhase bbI bbstudies bbinvolve bbhealthy bbhuman bbvolunteers bbwho
bbare bbusually bbpaid bbfor bbtheir bbparticipation. bbNurses bbmay
bbobserve bbfor bbadverse bbeffects bband bbtoxicity.
4. What bbconcept bbis bbconsidered bbwhen bbgeneric bbdrugs bbare
bbsubstituted bbfor bbbrandbbname bbdrugs?
A) Bioavailability
B) Critical bbconcentration
C) Distribution
D) Half-life
ANSWER: A
